Steward Partners Investment Advisory’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Steward Partners Investment Advisory’s Portfolio FNCH Stock Details FNCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-75	Closed	-$389	–	3634
2023 Q3	$389	Hold	75	–	–	﹤0.01%	3259
2023 Q2	$640	Hold	75	–	–	﹤0.01%	3176
2023 Q1	$884	Hold	75	–	–	﹤0.01%	3127
2022 Q4	$1.08K	Hold	75	–	–	﹤0.01%	3115
2022 Q3	$4K	Hold	75	–	–	﹤0.01%	2898
2022 Q2	$6K	Hold	75	–	–	﹤0.01%	2734
2022 Q1	$11K	Hold	75	–	–	﹤0.01%	2645
2021 Q4	$22K	Hold	75	–	–	﹤0.01%	2289
2021 Q3	$29K	Hold	75	–	–	﹤0.01%	2165
2021 Q2	$32K	Buy	+75	New	+$32.5K	﹤0.01%	4078

Other funds holding FNCH

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSAG

Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Steward Partners Investment Advisory's FNCH Position: Q4 2023 in Review

Steward Partners Investment Advisory sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q4 2023, closing a stake of 75 shares — an estimated $389 sold.

Steward Partners Investment Advisory first reported a position in FNCH in Q2 2021 and held it in 10 quarters. The position peaked at $32K in Q2 2021. 17 funds tracked by Wall St. Rank hold FNCH as of Q4 2023.

Steward Partners Investment Advisory reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Steward Partners Investment Advisory sold 75 Finch Therapeutics Group, Inc. Common Stock shares in Q4 2023, an estimated $389.
Steward Partners Investment Advisory first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
Steward Partners Investment Advisory's Finch Therapeutics Group, Inc. Common Stock position peaked at $32K in Q2 2021.
17 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q4 2023.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2023, filed 12 Feb 2024.